Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Ziphius Vaccines is developing a proprietary self-amplifying mRNA technology platform combined with innovative lipid formulations for delivery. saRNA or replicon RNA has the advantage of having self-replicating features.
Lead Product(s): ZIP-1642
Therapeutic Area: Infections and Infectious Diseases Product Name: ZIP-1642
Highest Development Status: PreclinicalProduct Type: Vaccine
Partner/Sponsor/Collaborator: Charles River Laboratories, Inc
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration June 23, 2022